Monthly Archives: July 2019

When Good Things DON’T Come to Those Who Wait: How Pharma Companies Compare in Governance Efficiency

2019-07-31T15:54:00+00:00

Predicting when a competing product will be approved is essential in any commercial forecast and for any business insights team with their eye on the market.  Here at OZMOSI, we have been spending our summer building out a machine learning approach to further improve our drug approval date forecasting.  Typically, the industry uses a simple average of phase lengths by disease area. While we have employed a similar approach historically, with 400,000 clinical trials in our database (and counting) we feel we can do better. In our analysis to date, we have gained some interesting perspective on the elements that go [...]

When Good Things DON’T Come to Those Who Wait: How Pharma Companies Compare in Governance Efficiency2019-07-31T15:54:00+00:00

Keeping up with the Pharmaceutical Industry in Asia

2019-07-08T13:19:44+00:00

Keeping up with pharmaceutical landscape around the world, especially in Asia, is essential in today’s market. Here are some of the biggest news stories emerging from Asian countries that are making big strides in drug development. China: Recently, China has been quickly advancing in the process of approving of new drugs. This is in accordance to the new drug registration procedure under the Chinese FDA(CFDA). This new process is helping China to beat other countries, including the US, in the process of bringing drugs to market. For example, China was able to grant Astrazeneca and FribroGen approval for the drug [...]

Keeping up with the Pharmaceutical Industry in Asia2019-07-08T13:19:44+00:00